Delia Dima
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 37
- Acute Myeloid Leukemia Research 16
- Multiple Myeloma Research and Treatments 6
- Hematopoietic Stem Cell Transplantation 6
- Chronic Myeloid Leukemia Treatments 6
- Co-authors
- Ciprian Tomuleasa (51 shared papers)Adrian P. Trifa (16 shared papers)Sergiu Paşca (23 shared papers)Mihnea Zdrenghea (20 shared papers)Claudia Bănescu (9 shared papers)Alina Tănase (15 shared papers)Patric Teodorescu (15 shared papers)Carmen Duicu (4 shared papers)
- Journals
- Journal of Clinical Medicine (6 papers)Frontiers in Oncology (5 papers)Blood Reviews (3 papers)Critical Reviews in Clinical Laboratory Sciences (2 papers)Pharmaceuticals (2 papers)
- Partner nations
- RomaniaUnited StatesGermany
In The Last Decade
Delia Dima
68 papers receiving 633 citations
Peers
Comparison fields: 5 of 84
- Hematology 240
- Genetics 139
- Oncology 173
- Immunology 118
- Pathology and Forensic Medicine 86
Countries citing papers authored by Delia Dima
This map shows the geographic impact of Delia Dima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delia Dima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delia Dima more than expected).
Fields of papers citing papers by Delia Dima
This network shows the impact of papers produced by Delia Dima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delia Dima. The network helps show where Delia Dima may publish in the future.
Co-authors
The 25 scholars most cited alongside Delia Dima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 39 | |
| 2 | 2014 | 38 | |
| 3 | 2019 | 35 | |
| 4 | 2018 | 30 | |
| 5 | 2014 | 28 | |
| 6 | 2021 | 24 | |
| 7 | 2010 | 22 | |
| 8 | 2019 | 21 | |
| 9 | 2017 | 19 | |
| 10 | 2019 | 18 | |
| 11 | 2018 | 18 | |
| 12 | 2020 | 17 | |
| 13 | 2021 | 16 | |
| 14 | 2015 | 16 | |
| 15 | 2020 | 16 | |
| 16 | Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia. | 2006 | 15 |
| 17 | 2019 | 15 | |
| 18 | 2023 | 11 | |
| 19 | 2019 | 10 | |
| 20 | 2015 | 10 |
About Delia Dima
Delia Dima is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Pathology and Forensic Medicine, having authored 70 papers that have together received 645 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (8 papers), Multiple Myeloma Research and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Hematology (240 citations), Genetics (139 citations), Oncology (173 citations), Immunology (118 citations) and Pathology and Forensic Medicine (86 citations). Delia Dima has collaborated with scholars based in Romania, United States and Germany. Frequent co-authors include Ciprian Tomuleasa, Adrian P. Trifa, Sergiu Paşca, Mihnea Zdrenghea, Claudia Bănescu, Alina Tănase, Patric Teodorescu, Carmen Duicu, Minodora Dobreanu and Bobe Petrushev. Their work appears in journals such as Journal of Clinical Medicine, Frontiers in Oncology, Blood Reviews, Critical Reviews in Clinical Laboratory Sciences and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.